EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Aflatoxin Exposure in Immunocompromised Patients: Current State and Future Perspectives

Temitope R Fagbohun iD, Queenta Ngum Nji iD, Viola O Okechukwu, Oluwasola A Adelusi iD, Lungani A Nyathi iD, Patience Awong iD, Patrick B Njobeh iD

Toxins · 16.08.2025 · 17 (8) · 414

DOI: 10.3390/toxins17080414 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Toxins, online erschienen am 16.08.2025. Verfasst von Temitope R Fagbohun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Food Technology, University of Johannesburg, Doornfontein Campus, Johannesburg 2094, South Africa. Hauptthemen laut MEDLINE: Aflatoxins, Immunocompromised Host. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 255 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Maize Trust, University of Johannesburg, South Africa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aflatoxins (AFs), harmful secondary metabolites produced by the genus Aspergillus, particularly Aspergillus flavus and Aspergillus parasiticus, are one of the best-known potent mycotoxins, posing a significant risk to public health. The primary type, especially aflatoxin B1 (AFB1), is a potent carcinogen associated with liver cancer, immunosuppression, and other health problems. Environmental factors such as high temperatures, humidity, and inadequate storage conditions promote the formation of aflatoxin in staple foods such as maize, peanuts, and rice. Immunocompromised individuals, including those with HIV/AIDS, hepatitis, cancer, or diabetes, are at increased risk due to their reduced detoxification capacity and weakened immune defenses. Chronic exposure to AF in these populations exacerbates liver damage, infection rates, and disease progression, particularly in developing countries and moderate-income populations where food safety regulations are inadequate and reliance on contaminated staple foods is widespread. Biomarkers such as aflatoxin-albumin complexes, urinary aflatoxin M1, and aflatoxin (AF) DNA adducts provide valuable insights but remain underutilized in resource-limited settings. Despite the globally recognized health risk posed by AF, research focused on monitoring human exposure remains limited, particularly among immunocompromised individuals. This dynamic emphasizes the need for targeted studies and interventions to address the particular risks faced by immunocompromised individuals. This review provides an up-to-date overview of AF exposure in immunocompromised populations, including individuals with cancer, hepatitis, diabetes, malnutrition, pregnant women, and the elderly. It also highlights exposure pathways, biomarkers, and biomonitoring strategies, while emphasizing the need for targeted interventions, advanced diagnostics, and policy frameworks to mitigate health risks in these vulnerable groups. Addressing these gaps is crucial to reducing the health burden and developing public health strategies in high-risk regions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AflatoxinsImmunocompromised HostHumansFood ContaminationAnimalsEnvironmental Exposure

Stichwörter der Autor:innen

aflatoxin biomarkersaflatoxinsdetection methodsexposure routeimmunocompromised patients

Substanzen

Aflatoxins

Autor:innen und Institutionen

  • Department of Biotechnology and Food Technology, University of Johannesburg, Doornfontein Campus, Johannesburg 2094, South Africa.
  • Department of Environmental, Water and Earth Sciences, Tshwane University of Technology, Arcadia Campus, Private Bag X680, Pretoria 0001, South Africa.
  • Centre for Innovative Food Research (CIFR), Department of Biotechnology and Food Technology, University of Johannesburg, Doornfontein Campus, Johannesburg 2094, South Africa.
  • Department of Health Sciences, University of Johannesburg, Doornfontein Campus, Johannesburg 2094, South Africa.

ORCID-Profile: Temitope R Fagbohun, Queenta Ngum Nji, Oluwasola A Adelusi, Lungani A Nyathi, Patience Awong, Patrick B Njobeh

Förderung

  • Maize Trust
  • University of Johannesburg, South Africa

Zitieren

APA

Fagbohun, T. R., Nji, Q. N., Okechukwu, V. O., Adelusi, O. A., Nyathi, L. A., Awong, P., & Njobeh, P. B. (2025). Aflatoxin Exposure in Immunocompromised Patients: Current State and Future Perspectives. Toxins, 17(8), 414. https://doi.org/10.3390/toxins17080414

Vancouver

Fagbohun TR, Nji QN, Okechukwu VO, Adelusi OA, Nyathi LA, Awong P, et al. Aflatoxin Exposure in Immunocompromised Patients: Current State and Future Perspectives. Toxins. 2025;17(8):414. doi:10.3390/toxins17080414

BibTeX
@article{Fagbohun2025,
  author = {Fagbohun, Temitope R and Nji, Queenta Ngum and Okechukwu, Viola O and Adelusi, Oluwasola A and Nyathi, Lungani A and Awong, Patience and Njobeh, Patrick B},
  title = {Aflatoxin Exposure in Immunocompromised Patients: Current State and Future Perspectives},
  journal = {Toxins},
  year = {2025},
  volume = {17},
  number = {8},
  pages = {414},
  doi = {10.3390/toxins17080414}
}
Kostenlos starten →